Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-20-012014
Filing Date
2020-11-09
Accepted
2020-11-09 16:16:13
Documents
90
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cbmg_10q.htm   iXBRL 10-Q 1341175
2 SPONSORED COLLABORATIVE RESEARCH AGREEMENT cbmg_ex104.htm EX-10.4 6222
3 CERTIFICATION cbmg_ex311.htm EX-31.1 10583
4 CERTIFICATION cbmg_ex321.htm EX-32.1 4798
5 GRAPHIC cbmg_ex104img1.jpg GRAPHIC 202473
6 GRAPHIC cbmg_ex104img2.jpg GRAPHIC 232746
7 GRAPHIC cbmg_ex104img3.jpg GRAPHIC 238128
8 GRAPHIC cbmg_ex104img4.jpg GRAPHIC 255681
9 GRAPHIC cbmg_ex104img5.jpg GRAPHIC 201050
10 GRAPHIC cbmg_ex104img6.jpg GRAPHIC 258465
11 GRAPHIC cbmg_ex104img7.jpg GRAPHIC 205886
12 GRAPHIC cbmg_ex104img8.jpg GRAPHIC 227305
13 GRAPHIC cbmg_ex104img9.jpg GRAPHIC 96609
14 GRAPHIC cbmg_ex104img10.jpg GRAPHIC 22981
15 GRAPHIC docaavqjimg56.jpg GRAPHIC 39015
16 GRAPHIC docaavqjimg57.jpg GRAPHIC 34265
  Complete submission text file 0001654954-20-012014.txt   7971116

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE cbmg-20200930.xsd EX-101.SCH 44389
18 XBRL CALCULATION FILE cbmg-20200930_cal.xml EX-101.CAL 51354
19 XBRL DEFINITION FILE cbmg-20200930_def.xml EX-101.DEF 125168
20 XBRL LABEL FILE cbmg-20200930_lab.xml EX-101.LAB 283777
21 XBRL PRESENTATION FILE cbmg-20200930_pre.xml EX-101.PRE 251152
22 EXTRACTED XBRL INSTANCE DOCUMENT cbmg_10q_htm.xml XML 775346
Mailing Address 209 PERRY PARKWAY SUITE 13 GAITHERSBURG MD 20877
Business Address 209 PERRY PARKWAY SUITE 13 GAITHERSBURG MD 20877 (301) 825 5320
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36498 | Film No.: 201297886
SIC: 2836 Biological Products, (No Diagnostic Substances)